|
GART expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67529999872684E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28269999463993E-08 |
| Normal-vs-Stage2 |
6.34469999999387E-05 |
| Normal-vs-Stage3 |
1.56939999995664E-07 |
| Normal-vs-Stage4 |
2.940300E-03 |
| Stage1-vs-Stage2 |
9.376600E-01 |
| Stage1-vs-Stage3 |
3.838400E-01 |
| Stage1-vs-Stage4 |
3.906200E-01 |
| Stage2-vs-Stage3 |
5.143000E-01 |
| Stage2-vs-Stage4 |
5.192800E-01 |
| Stage3-vs-Stage4 |
1.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53879999964524E-07 |
| Normal-vs-AfricanAmerican |
1.011390E-04 |
| Normal-vs-Asian |
1.176820E-01 |
| Caucasian-vs-AfricanAmerican |
6.753200E-01 |
| Caucasian-vs-Asian |
6.608600E-01 |
| AfricanAmerican-vs-Asian |
5.906200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05220001997719E-09 |
| Normal-vs-Female |
3.50500000000364E-05 |
| Male-vs-Female |
7.429900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.677720E-02 |
| Normal-vs-Age(41-60Yrs) |
1.92260000031474E-07 |
| Normal-vs-Age(61-80Yrs) |
2.87460000025774E-07 |
| Normal-vs-Age(81-100Yrs) |
6.597400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.998200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.701200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.066000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.943200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.728800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.974600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.037250E-01 |
| Normal-vs-Grade 2 |
1.55549999547588E-08 |
| Normal-vs-Grade 3 |
4.52489999913652E-08 |
| Normal-vs-Grade 4 |
4.023300E-03 |
| Grade 1-vs-Grade 2 |
2.905800E-01 |
| Grade 1-vs-Grade 3 |
3.242400E-01 |
| Grade 1-vs-Grade 4 |
7.373200E-01 |
| Grade 2-vs-Grade 3 |
7.488800E-01 |
| Grade 2-vs-Grade 4 |
4.385600E-01 |
| Grade 3-vs-Grade 4 |
3.571800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.86819999978572E-07 |
| Normal-vs-ccB subtype |
1.9220000002651E-07 |
| ccA subtype-vs-ccB subtype |
2.599600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32629999982647E-07 |
| Normal-vs-N1 |
5.159000E-01 |
| N0-vs-N1 |
3.262200E-01 |
|
|
